Inflammatix

About:

Inflammatix develops rapid immune system diagnostics to improve patient care and public health.

Website: https://www.inflammatix.com

Twitter/X: inflammatix_inc

Top Investors: Khosla Ventures, Leblon Capital, National Institutes of Health, Northpond Ventures, DARPA

Description:

Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.